Cargando…

Recent Discoveries of Diagnostic, Prognostic and Predictive Biomarkers for Pancreatic Cancer

SIMPLE SUMMARY: Biomarkers for cancer diagnosis, prognosis and prediction are important tools and an urgent need in precision medicine for pancreatic cancer. In recent years, many experimental and clinical studies aimed at identifying new biomarkers for pancreatic ductal adenocarcinoma. In the revie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khomiak, Andrii, Brunner, Marius, Kordes, Maximilian, Lindblad, Stina, Miksch, Rainer Christoph, Öhlund, Daniel, Regel, Ivonne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692691/ https://www.ncbi.nlm.nih.gov/pubmed/33147766 http://dx.doi.org/10.3390/cancers12113234

Ejemplares similares

Current Strategies and Future Perspectives for Precision Medicine in Pancreatic Cancer
por: Regel, Ivonne, et al.
Publicado: (2020)

Loss of Ifnar1 in Pancreatic Acinar Cells Ameliorates the Disease Course of Acute Pancreatitis
por: Miller, Katharina J., et al.
Publicado: (2015)

Prognostic Impact of Tumor-Infiltrating Lymphocytes and Neutrophils on Survival of Patients with Upfront Resection of Pancreatic Cancer
por: Miksch, Rainer C., et al.
Publicado: (2019)

Molecular, morphological and survival analysis of 177 resected pancreatic ductal adenocarcinomas (PDACs): Identification of prognostic subtypes
por: Schlitter, Anna Melissa, et al.
Publicado: (2017)

Role of stereotactic body radiation in the enhancement of the quality of life in locally advanced pancreatic adenocarcinoma: a systematic review
por: Vornhülz, Marlies, et al.
Publicado: (2022)

Hypoxia-induced endoplasmic reticulum stress characterizes a necrotic phenotype of pancreatic cancer
por: Kong, Bo, et al.
Publicado: (2015)

Serum Tumor Markers in Pancreatic Cancer—Recent Discoveries
por: Rückert, Felix, et al.
Publicado: (2010)

COVID-19 infection in patients with acute pancreatitis – particularities of clinical presentation and management
por: Rotar, O., et al.
Publicado: (2021)

Polycomb repressor complex 1 promotes gene silencing through H2AK119 mono-ubiquitination in acinar-to-ductal metaplasia and pancreatic cancer cells
por: Benitz, Simone, et al.
Publicado: (2015)

Pancreatic panniculitis and elevated serum lipase in metastasized acinar cell carcinoma of the pancreas: A case report and review of literature
por: Miksch, Rainer Christoph, et al.
Publicado: (2020)

Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma
por: Cheng, Yang, et al.
Publicado: (2019)

Circulating Tissue Polypeptide-Specific Antigen in Pre-Diagnostic Pancreatic Cancer Samples
por: Borgmästars, Emmy, et al.
Publicado: (2021)

Novel prognostic markers within the CD44‐stromal ligand network in pancreatic cancer
por: Franklin, Oskar, et al.
Publicado: (2018)

A Cross-Sectional and Longitudinal Analysis of Pre-Diagnostic Blood Plasma Biomarkers for Early Detection of Pancreatic Cancer
por: Mason, James, et al.
Publicado: (2022)

Survival Benefits of Chemotherapy for Patients with Advanced Pancreatic Cancer in A Clinical Real-World Cohort
por: Kordes, Maximilian, et al.
Publicado: (2019)

Discovery and Validation of Circulating EVL mRNA as a Prognostic Biomarker in Pancreatic Cancer
por: Du, Yan, et al.
Publicado: (2021)

Capability and Limitations of Recent Diagnostic Criteria for Autoimmune Pancreatitis
por: Tabata, Taku, et al.
Publicado: (2013)

Recent advances in the diagnostic evaluation of pancreatic cystic lesions
por: Ardeshna, Devarshi R, et al.
Publicado: (2022)

Progress on diagnostic and prognostic markers of pancreatic cancer
por: YANG, HONG, et al.
Publicado: (2023)

ITGA3 serves as a diagnostic and prognostic biomarker for pancreatic cancer
por: Jiao, Yan, et al.
Publicado: (2019)

Diagnostic, Predictive and Prognostic Molecular Biomarkers in Pancreatic Cancer: An Overview for Clinicians
por: Giannis, Dimitrios, et al.
Publicado: (2021)

The role of diagnostic, prognostic, and predictive biomarkers in the management of early pancreatic cancer
por: Maloney, Sarah, et al.
Publicado: (2023)

Risk of Developing Pancreatic Cancer in Patients with Chronic Pancreatitis
por: Vujasinovic, Miroslav, et al.
Publicado: (2020)

Circulating Monocytes Serve as Novel Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma Patients
por: Hansen, Frederik J., et al.
Publicado: (2023)

Variations in the management of diarrhoea induced by cancer therapy: results from an international, cross-sectional survey among European oncologists
por: Kordes, Maximilian, et al.
Publicado: (2019)

Recent Advances in Proteomics and Cancer Biomarker Discovery
por: Xiao, Gary Guishan, et al.
Publicado: (2008)

Recent Advances in the Discovery of Biomarkers for Canine Osteosarcoma
por: Luu, Anita K., et al.
Publicado: (2021)

Plasma and tumor levels of Linc-pint are diagnostic and prognostic biomarkers for pancreatic cancer
por: Li, Le, et al.
Publicado: (2016)

An Integrated Microarray Analysis Reveals Significant Diagnostic and Prognostic Biomarkers in Pancreatic Cancer
por: Yang, Zhi-Qiang, et al.
Publicado: (2020)

Screening of Exosome-Derived Proteins and Their Potential as Biomarkers in Diagnostic and Prognostic for Pancreatic Cancer
por: Marin, Anelis Maria, et al.
Publicado: (2023)

Screening for pancreatic cancer in individuals with genetic susceptibility
por: Grützmann, Robert, et al.
Publicado: (2023)

c-Met and PD-L1 on Circulating Exosomes as Diagnostic and Prognostic Markers for Pancreatic Cancer
por: Lux, Alexander, et al.
Publicado: (2019)

Recent Advances in Pancreatic Cancer: Novel Prognostic Biomarkers and Targeted Therapy—A Review of the Literature
por: Schlick, Konstantin, et al.
Publicado: (2021)

Systems Biology and the Discovery of Diagnostic Biomarkers
por: Wang, Kai, et al.
Publicado: (2010)

Outcomes and risks in palliative pancreatic surgery: an analysis of the German StuDoQ|Pancreas registry
por: Hofmann, Felix O., et al.
Publicado: (2022)

Comparison of hepatic and serum lipid signatures in hepatocellular carcinoma patients leads to the discovery of diagnostic and prognostic biomarkers
por: Lu, Yonghai, et al.
Publicado: (2017)

Discovery of Pancreatic Adenocarcinoma Biomarkers by Untargeted Metabolomics
por: Martín-Blázquez, Ariadna, et al.
Publicado: (2020)

Serum APN/CD13 as a novel diagnostic and prognostic biomarker of pancreatic cancer
por: Pang, Li, et al.
Publicado: (2016)

Mitochondrial DNA and MitomiR Variations in Pancreatic Cancer: Potential Diagnostic and Prognostic Biomarkers
por: Moro, Loredana
Publicado: (2021)

Targeting Tumor-Stromal Interactions in Pancreatic Cancer: Impact of Collagens and Mechanical Traits
por: Maneshi, Parniyan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qscg3gmhaf7evfmnohhs8of9i6